VEGFA and prostate cancer: Genistein (4′,5,7-trihydroxyisoflavone), a soy phytoestrogen, has been the subject of multiple studies revealing its significant ability to suppress the baseline and hypoxia-triggered VEGF level in HUVECs and prostate cancer.